AKT protein kinase inhibitors
US8680114B2 · kind B2 · utility
5Cited by
14References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 25, 2009 |
| Grant date | Mar 25, 2014 |
| Priority date | — |
| Expiry date | Jan 5, 2033 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10T428/31855
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides compounds, including resolved enantiomers, diastereomers, solvates and pharmaceutically acceptable salts thereof, comprising the Formula:A-L-CRwhere CR is a cyclical core group, L is a linking group and A is as defined herein. Also provided are methods of using the compounds of this invention as AKT protein kinase inhibitors and for the treatment of hyperproliferative diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.